| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/16/2005 | CN1593390A Usage of honokiol in the preparing process of anti tumor angiopoiesis medicine |
| 03/16/2005 | CN1593389A Cool plaster and its processing method and usage |
| 03/16/2005 | CN1593355A Non-homogeneous pharmaceutical elution supporting stand |
| 03/16/2005 | CN1593224A Apple vinegar nutritious product and its production method |
| 03/16/2005 | CN1593217A Hair tonic amino acid and its preparation method |
| 03/16/2005 | CN1593211A Chitin sauce food and its preparation method |
| 03/16/2005 | CN1593205A Chitin pickled vegetable and its preparation method |
| 03/16/2005 | CN1193048C 聚合物水分散体 Aqueous polymer dispersions |
| 03/16/2005 | CN1193036C Method of preparing clarithromycin of form II crystals |
| 03/16/2005 | CN1193029C New 7-amino pyrido[2, 3-d] pyrimidine derivative, its composition and use |
| 03/16/2005 | CN1193028C Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof |
| 03/16/2005 | CN1193027C Substituted pyrroles |
| 03/16/2005 | CN1193026C Z-pyrazoline-5-ones |
| 03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
| 03/16/2005 | CN1193024C Process for producing optically active sulfoxide devivative' |
| 03/16/2005 | CN1193019C Method and reagents for N-alkylating ureides |
| 03/16/2005 | CN1193014C Novol pyrrole sulphamide compound |
| 03/16/2005 | CN1193010C Heterocyclonitrogen heteroethane derivant with antiviral activity |
| 03/16/2005 | CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 03/16/2005 | CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
| 03/16/2005 | CN1192999C Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors |
| 03/16/2005 | CN1192802C Bioactivity compound bone material and preparation method thereof |
| 03/16/2005 | CN1192800C Trapping agent for blood carbonyl compounds |
| 03/16/2005 | CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV) |
| 03/16/2005 | CN1192780C Therapeutical agent |
| 03/16/2005 | CN1192779C Extraction process of acetylated aloe glucomannan |
| 03/16/2005 | CN1192778C Tumor cell growth inhibitor and its prepn process |
| 03/16/2005 | CN1192777C Use of a indolequinoxaline compound for preparing multiple sclerosis a drug |
| 03/16/2005 | CN1192776C Dermatitis treating medicine |
| 03/16/2005 | CN1192775C Prophylactic and therapeutic use of oltipraz as antifibrotic and anticirrhotic agent in liver and pharmaceutical composition containing oltipraz |
| 03/16/2005 | CN1192774C Integerrimine liposome gel preparation and preparing method |
| 03/16/2005 | CN1192773C Cyclic amine CCR3 antagonisis |
| 03/16/2005 | CN1192772C Application of epigallic catechin 3-gallate in treating HPV infection |
| 03/16/2005 | CN1192771C Medicine for treating rheumatism and rheumatoid disease |
| 03/16/2005 | CN1192770C Wet keeping dressing for wound medicine |
| 03/16/2005 | CN1192769C Medicinal compositions for treating lower uropathy |
| 03/16/2005 | CN1192768C Naphthoquinone derivatives and their use in the treatment and control of tuberculosis |
| 03/16/2005 | CN1192765C New and improved formulation for paclitaxel |
| 03/16/2005 | CN1192764C Cosmetic compositions containing substituted amine derivatives |
| 03/16/2005 | CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them |
| 03/15/2005 | US6867334 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743 |
| 03/15/2005 | US6867316 Antitumor |
| 03/15/2005 | US6867306 Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds |
| 03/15/2005 | US6867305 For cancer therapy |
| 03/15/2005 | US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents |
| 03/15/2005 | US6867288 Polycystic kidney disease gene |
| 03/15/2005 | US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus |
| 03/15/2005 | US6867238 Compositions for the treatment and prevention of cancer |
| 03/15/2005 | US6867236 Method of preventing of delaying the onset and progression of Alzheimer's disease and related disorders |
| 03/15/2005 | US6867235 Helianthrone derivatives as anti-cancer agents |
| 03/15/2005 | US6867234 Fat composition for oral or enternal administration and hexacosanoic acid depressant |
| 03/15/2005 | US6867231 Therapeutic systems |
| 03/15/2005 | US6867230 Antibacterial and antiprotozoal agents |
| 03/15/2005 | US6867229 Antiparasitic composition for the treatment and protection of pets |
| 03/15/2005 | US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer |
| 03/15/2005 | US6867226 Preventing diarrhea |
| 03/15/2005 | US6867225 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid |
| 03/15/2005 | US6867224 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid |
| 03/15/2005 | US6867222 Nociceptin analogs |
| 03/15/2005 | US6867221 Cyclic amine compounds and pharmaceutical composition containing the same |
| 03/15/2005 | US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 03/15/2005 | US6867219 Antitumor agents |
| 03/15/2005 | US6867218 An arylene or heteroarylene alkoxy or hydroxy-propionic acid or ester derivatives; treatment or prevention of Peroxisome Proliferator-Activated Receptors; diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 03/15/2005 | US6867216 Inhibitors of hedgehog signal pathways, compositions and uses related thereto |
| 03/15/2005 | US6867215 Cardioprotective phosphonates and malonates |
| 03/15/2005 | US6867214 Quinazoline derivatives and pharmaceutical applications thereof |
| 03/15/2005 | US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol |
| 03/15/2005 | US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release |
| 03/15/2005 | US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/15/2005 | US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof |
| 03/15/2005 | US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance |
| 03/15/2005 | US6867204 Benzoxazine derivatives and uses thereof |
| 03/15/2005 | US6867201 For therapy of abnormal cell growth, such as cancer, in mammals |
| 03/15/2005 | US6867200 Anticancer agents; anticoagulants |
| 03/15/2005 | US6867199 Clearing retained mucous secretions, balancing tissue hydration and fluid secretion, and/or inhibiting or preventing early stages of platelet activation, degranulation and aggregation |
| 03/15/2005 | US6867196 Injecting into blood vessel near or in heart muscle; limiting invasiveness |
| 03/15/2005 | US6867194 A sugar-modified linsidomine (SIN-1) comprising a sugar moiety, a SIN-1 moiety and a glycosidic bond disposed between them, deliver nitric oxide following activation by a glycosidase |
| 03/15/2005 | US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 03/15/2005 | US6867178 Calorically dense nutritional composition |
| 03/15/2005 | US6867033 By administration of PV virus-like particles (VLPs) to a patient suffering from the PV infection |
| 03/15/2005 | US6867024 Ubiquinone composition and methods related thereto |
| 03/15/2005 | US6866999 Method for identifying increased risk of death from community acquired pneumonia |
| 03/15/2005 | US6866992 Aqueous solution comprising sodium chloride, sodium citrate, sodium acetate, sodium phosphate and a psoralen; stoichiometry, nonsettling of psoralen |
| 03/15/2005 | US6866873 Nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity |
| 03/15/2005 | US6866869 Liquid antimicrobial compositions |
| 03/15/2005 | US6866866 Once a day dosage for noninsulin dependent diabetes mellitus; maintains bioavailability is presence of food |
| 03/15/2005 | US6866864 Compositions and methods of use in the treatment of angiogenesis and vascular-related disorders |
| 03/15/2005 | US6866857 Oxalipatinum preparation packaging |
| 03/15/2005 | US6866856 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis |
| 03/15/2005 | US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell |
| 03/15/2005 | US6866839 Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| 03/15/2005 | US6866838 Composite nanospheres and their conjugates with biomolecules |
| 03/15/2005 | CA2382549C Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 03/15/2005 | CA2334870C Polymorphic form of clopidogrel hydrogen sulphate |
| 03/15/2005 | CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists |
| 03/15/2005 | CA2321336C Synthesis of carbamate ketolide antibiotics |
| 03/15/2005 | CA2255659C Neuroactive peptides |
| 03/15/2005 | CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
| 03/15/2005 | CA2242972C Anthelmintic paste |